General Information of Disease (ID: DIS2FDOT)

Disease Name Obstructive jaundice
Synonyms obstructive hyperbilirubinemia; cholestatic jaundice syndrome; cholestatic jaundice
Definition A finding indicating increased bilirubin levels in the blood and urine, due to intrahepatic or extrahepatic obstruction of the biliary system.
Disease Hierarchy
DISUV4DU: Non-neoplastic bile duct disorder
DISDJJWE: Cholestasis
DIS2FDOT: Obstructive jaundice
Disease Identifiers
MONDO ID
MONDO_0006874
MESH ID
D041781
UMLS CUI
C0022354
MedGen ID
43988
SNOMED CT ID
44018007

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Menadiol sodium diphosphate DMP9N85 Approved Small molecular drug [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 11 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
BRD1 TTT09OB Limited Biomarker [2]
DAO TT7Y3EJ moderate Altered Expression [3]
SLC10A1 TTWZRY5 moderate Altered Expression [4]
ABCB4 TTJUXV6 Strong Biomarker [5]
ADM TTV14YH Strong Biomarker [6]
CD14 TT6I7DC Strong Biomarker [7]
CFH TTUW6OP Strong Biomarker [6]
LBP TTVQJLY Strong Biomarker [7]
PCNA TTLG1PD Strong Therapeutic [8]
PNPLA6 TTWAQU2 Strong Genetic Variation [9]
UCP2 TTSC2YM Strong Biomarker [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 DTT(s)
This Disease Is Related to 1 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC25A13 DTDSYAQ moderate Genetic Variation [11]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
GPT DER5HFI Limited Biomarker [12]
------------------------------------------------------------------------------------
This Disease Is Related to 5 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
OPN1MW OTPJ7LX4 Limited Biomarker [13]
PPP1R15A OTYG179K Limited Altered Expression [2]
AIP OTDJ3OSV moderate Biomarker [14]
NPHP3 OT8U8ELA moderate Genetic Variation [15]
GGTLC1 OTWJKUHQ Strong Biomarker [16]
------------------------------------------------------------------------------------

References

1 Menadiol sodium diphosphate FDA Label
2 Yinchenhao decoction attenuates obstructive jaundice-induced liver injury and hepatocyte apoptosis by suppressing protein kinase RNA-like endoplasmic reticulum kinase-induced pathway.World J Gastroenterol. 2019 Nov 7;25(41):6205-6221. doi: 10.3748/wjg.v25.i41.6205.
3 Intestinal mucosal injury induced by obstructive jaundice is associated with activation of TLR4/TRAF6/NF-B pathways.PLoS One. 2019 Oct 31;14(10):e0223651. doi: 10.1371/journal.pone.0223651. eCollection 2019.
4 Sodium Taurocholate Cotransporting Polypeptide (NTCP) Deficiency Hidden Behind Citrin Deficiency in Early Infancy: A Report of Three Cases.Front Genet. 2019 Nov 7;10:1108. doi: 10.3389/fgene.2019.01108. eCollection 2019.
5 Hepatocyte IKK2 protects Mdr2-/- mice from chronic liver failure.PLoS One. 2011;6(10):e25942. doi: 10.1371/journal.pone.0025942. Epub 2011 Oct 14.
6 Human adrenomedullin and its binding protein ameliorate sepsis-induced organ injury and mortality in jaundiced rats.Peptides. 2010 May;31(5):872-7. doi: 10.1016/j.peptides.2010.01.010. Epub 2010 Feb 2.
7 The kinetic expression of lipopolysaccharide-binding protein and CD14 gene in obstructive jaundice.J Invest Surg. 2015 Feb;28(1):18-23. doi: 10.3109/08941939.2014.943858. Epub 2014 Aug 5.
8 Obstructive jaundice alters proliferating cell nuclear antigen expression in rat small intestine.World J Surg. 2003 Oct;27(10):1161-4. doi: 10.1007/s00268-003-6992-x. Epub 2003 Aug 18.
9 The clinical spectrum of inherited diseases involved in the synthesis and remodeling of complex lipids. A tentative overview.J Inherit Metab Dis. 2015 Jan;38(1):19-40. doi: 10.1007/s10545-014-9776-6. Epub 2014 Nov 21.
10 Bile duct obstruction is associated with early postoperative upregulation of liver uncoupling protein-2 and reduced circulating glucose concentration in the rat.Nutrition. 2010 Apr;26(4):405-10. doi: 10.1016/j.nut.2009.05.005. Epub 2009 Jul 24.
11 Neonatal intrahepatic cholestasis caused by citrin deficiency: prevalence and SLC25A13 mutations among Thai infants.BMC Gastroenterol. 2012 Oct 15;12:141. doi: 10.1186/1471-230X-12-141.
12 A Simple and Easily Reproducible Model of Reversible Obstructive Jaundice in Rats.In Vivo. 2019 May-Jun;33(3):699-706. doi: 10.21873/invivo.11528.
13 Endoscopic papillary large balloon dilatation for the extraction of common bile duct stones.Rev Esp Enferm Dig. 2019 May;111(5):358-363. doi: 10.17235/reed.2019.5865/2018.
14 Autoimmune Pancreatitis.Am J Gastroenterol. 2018 Sep;113(9):1301. doi: 10.1038/s41395-018-0146-0. Epub 2018 Jun 18.
15 Isosorbide dinitrate in nephronophthisis treatment.Am J Med Genet A. 2018 Apr;176(4):1023-1026. doi: 10.1002/ajmg.a.38650.
16 Not only Alagille syndrome. Syndromic paucity of interlobular bile ducts secondary to HNF1 deficiency: a case report and literature review.Ital J Pediatr. 2019 Feb 21;45(1):27. doi: 10.1186/s13052-019-0617-y.